If you enjoy this content, please share it with a colleague
RELATED CONTENT
February 24, 2021 — Frost & Sullivan's recent analysis, Technological Advancements and Emerging Applications in the ...
September 3, 2020 — Based on its recent analysis of the global breast imaging workstation industry, Frost & Sullivan ...
Mach7 Technologies has been named the Asia Pacific Medical Imaging Informatics Company of the Year by global consulting firm Frost & Sullivan. Each year Frost & Sullivan presents this award to the company that demonstrates outstanding achievement and superior performance in the field of medical imaging informatics.
Frost & Sullivan released its list of top medical technologies for 2015, featuring an array of sophisticated inventions in medical devices, diagnostics and imaging. These innovations have given birth to less expensive and flexible healthcare solutions; playing a critical role in managing the increasing frequency of chronic diseases around the globe.
The U.S. medical imaging industry is experimenting with big data analytics solutions to measure, demonstrate and improve its value proposition. Analysis from Frost & Sullivan, “Big Data Opportunities in the US Medical Imaging Marketâ€, finds the market earned revenues of $39 million in 2014, and estimates this to reach $82 million by 2019 at a compound annual growth rate of 16 percent.
Although the highly saturated picture archiving and communication systems (PACS) segment is slowing growth in the U.S. imaging informatics market, a few niche areas are advancing forming new growth areas.
Growing awareness of the harmful effects of radiation exposure is driving the uptake of ultrasound systems, which are radiation free, less expensive, and more versatile than bigger modalities such as magnetic resonance (MR).
September 4, 2014 — Based on its recent analysis of the breast imaging solutions market, Frost & Sullivan recognized Volpara Solutions with the 2014 North American Frost & Sullivan Award for Technology Innovation Leadership.
A recent whitepaper by the Economist Intelligence Unit deems value in the “emerging new currency within health markets.” Since medical imaging represents a fairly large segment of the broader healthcare market and certainly one of the most capital-intensive — even if dwarfed in size by other segments such as its pharmaceutical counterpart — this farsighted statement begs the question, “Would saying value has already emerged as a major new currency within the U.S. medical imaging market be too much of an overstatement?”
April 1, 2014 — Based on its recent analysis of the non-melanoma skin cancer therapy market, Frost & Sullivan recognized Sensus Healthcare LLC with the 2014 North American Frost & Sullivan Award for New Product Innovation Leadership. Sensus uses a technique known as superficial radiation therapy (SRT) in its two low-energy X-ray devices, SRT-100 and SRT-100 Vision.